{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:01:39Z","timestamp":1792008099373,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.yrtph.2024.105770","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:11:07Z","timestamp":1735603867000},"page":"105770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The dual endothelin A and angiotensin II type 1 receptor antagonist sparsentan (FILSPARI\u00ae) exhibits a safe nonclinical male fertility toxicity profile"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6121-3784","authenticated-orcid":false,"given":"Patricia W.","family":"Bedard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tacey","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E.","family":"Kohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.yrtph.2024.105770_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0960-0760(95)00248-0","article-title":"In vitro studies of the subtypes of endothelin (ET) receptors present in the rat testis, and of their involvement in the secretory response of Leydig cells to ET-1","volume":"57","author":"Belloni","year":"1996","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.yrtph.2024.105770_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.yrtph.2024.105770_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/j.1939-4640.1996.tb01801.x","article-title":"Effects of endothelin-1 on the rat testicular vasculature","volume":"17","author":"Collin","year":"1996","journal-title":"J. Androl."},{"issue":"2","key":"10.1016\/j.yrtph.2024.105770_bib4","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.0.136R001","article-title":"Endothelin stimulates testosterone secretion by rat Leydig cells","volume":"136","author":"Conte","year":"1993","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.yrtph.2024.105770_bib5","first-page":"327","article-title":"An evaluation of reproductive and developmental toxicity of sitaxentan (Thelin) in rats. Birth Defects Res., Part B Dev","volume":"95","author":"Cross","year":"2012","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2024.105770_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yrtph.2012.05.018","article-title":"Evaluation of sitaxentan (Thelin\u00ae) toxicity in juvenile rats and regulatory interactions during the development of a European Medicines Agency pediatric investigation plan","volume":"64","author":"Cross","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yrtph.2024.105770_bib7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1210\/endo.132.2.8425480","article-title":"Endothelin-1 promotes steroidogenesis and stimulates protooncogene expression in transformed murine Leydig cells","volume":"132","author":"Ergul","year":"1993","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.yrtph.2024.105770_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s004290050221","article-title":"Endothelin and endothelin receptors A and B in the human testis","volume":"199","author":"Erg\u00fcn","year":"1999","journal-title":"Anat. Embryol."},{"key":"10.1016\/j.yrtph.2024.105770_bib14","series-title":"COZAAR (Losartan)","year":"1995"},{"key":"10.1016\/j.yrtph.2024.105770_bib15","series-title":"DIOVAN (Valsartan)","year":"1996"},{"key":"10.1016\/j.yrtph.2024.105770_bib16","series-title":"AVAPRO (Irbesartan)","year":"1997"},{"issue":"12","key":"10.1016\/j.yrtph.2024.105770_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/CS20190464","article-title":"Endothelin receptor antagonism during preeclampsia: a matter of timing?","volume":"133","author":"Hitzerd","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"issue":"11","key":"10.1016\/j.yrtph.2024.105770_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/CS20240249","article-title":"Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease","volume":"138","author":"Kohan","year":"2024","journal-title":"Clin. Sci."},{"key":"10.1016\/j.yrtph.2024.105770_bib29","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.yrtph.2024.105770_bib30","first-page":"896","article-title":"Endothelin and endothelin antagonists in chronic kidney disease","volume":"86","author":"Kohan","year":"2014","journal-title":"K I"},{"issue":"4","key":"10.1016\/j.yrtph.2024.105770_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-011-0602-5","article-title":"Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure","volume":"383","author":"M\u00fcller-Fielitz","year":"2011","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.yrtph.2024.105770_bib32","series-title":"Reproducibility and Replicability in Science","year":"2019"},{"issue":"11","key":"10.1016\/j.yrtph.2024.105770_bib34","first-page":"3797","article-title":"Gene expression of endothelin-1, endothelin-converting enzyme-1, and endothelin receptors in human epididymis","volume":"82","author":"Peri","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.yrtph.2024.105770_bib35","doi-asserted-by":"crossref","DOI":"10.1042\/bst021364s","article-title":"Endothelin-1 stimulates inositol phosphate production in rat testis","volume":"21","author":"Rudge","year":"1993","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.yrtph.2024.105770_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1095\/biolreprod55.1.25","article-title":"Direct visualization of rat peritubular myoid cell contraction in response to endothelin","volume":"55","author":"Tripiciano","year":"1996","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.yrtph.2024.105770_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1096\/fasebj.11.4.9068617","article-title":"Dual control of seminiferous tubule contractility mediated by ETA and ETB endothelin receptor subtypes","volume":"11","author":"Tripiciano","year":"1997","journal-title":"FASEB J"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230024002113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230024002113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T11:29:53Z","timestamp":1739273393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230024002113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":21,"alternative-id":["S0273230024002113"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105770","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dual endothelin A and angiotensin II type 1 receptor antagonist sparsentan (FILSPARI\u00ae) exhibits a safe nonclinical male fertility toxicity profile","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105770"}}